Background illustration for clinical trials search

Paid Clinical Trials Montreal

Discover 1,169 paid clinical trials in Montreal, Quebec. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2
Active & Responsive

Study of Iberdomide, Bortezomib, Dexamethasone With Isatuximab Added on Demand for ND-NTE MM Patients

for
Multiple Myeloma
Location: Montreal, Toronto, London, Halifax, St. John's,
Sponsor: Canadian Myeloma Research Group

Sex: All

Age: 65+

Code: NCT05272826

Phase 2, Recruiting
Active & Responsive

Quebec Pancreas Cancer Study

for
Pancreas Cancer, Pancreatic Cancer, Pancreas Neoplasm,
Location: Montreal
Sponsor: George Zogopoulos

Sex: All

Age: 18+

Code: NCT04104230

Recruiting
Active & Responsive

A Study of Pembrolizumab (MK-3475) With or Without Intismeran Autogene (V940) in Participants With Non-small Cell Lung Cancer (V940-009/INTerpath-009)

for
Carcinoma, Non-Small-Cell Lung
Location: Montreal, Quebec, Kingston, East Syracuse NY,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT06623422

Phase 3, Recruiting
Active & Responsive

Multicenter Clinical Trial of ST-02 for Ablation of Upper Tract Urothelial Carcinoma

for
Urothelial Carcinoma of the Renal Pelvis and Ureter,
Location: Montreal, Toronto, London, Halifax, Winnipeg, Vancouver
Sponsor: Peter Black

Sex: All

Age: 18+

Code: NCT06124976

Phase 2, Phase 3, Recruiting
Active & Responsive

ARC101 in Advanced Solid Tumors

for
Advanced Solid Tumor
Location: Montreal, Toronto, Vancouver
Sponsor: Third Arc Bio

Sex: All

Age: 18+

Code: NCT06672185

Phase 1, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image
Active & Responsive

Effectiveness of Empagliflozin Added to Automated Insulin Delivery (AID) Systems in Adults With Type 1 Diabetes With Sub-optimal Glycemic Outcomes

for
Type 1 Diabetes
Location: Montreal
Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre

Sex: All

Age: 18+

Code: NCT06021145

Recruiting
Active & Responsive

Pembrolizumab With or Without Maintenance Sacituzumab Tirumotecan (Sac-TMT; MK-2870) in Metastatic Squamous Non-small Cell Lung Cancer (NSCLC) [MK-2870-023]

for
Non-small Cell Lung Cancer, NSCLC
Location: Montreal, Trois-Rivieres, Kingston, Hackensack NJ,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT06422143

Phase 3, Recruiting
Active & Responsive

Cognitive Behavioral Therapy for Adolescents With Attention-Deficit / Hyperactivity Disorder

for
Attention Deficit Hyperactivity Disorder
Location: Montreal
Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre

Sex: All

Age: 13 - 17

Code: NCT02566824

Recruiting
Active & Responsive

Effect of Metformin on Behaviour and the Brain in Children Treated for a Brain Tumour

for
Medulloblastoma, Childhood, Cognitive Impairment
Location: Montreal, Sherbrooke, Ottawa, Quebec, Toronto, Hamilton,
Sponsor: Donald Mabbott

Sex: All

Age: 7 - 21

Code: NCT05230758

Phase 3, Recruiting
Active & Responsive

Pilot Study of IT Topotecan and Maintenance Chemotherapy for HR-EBTs in Children < 6 Years, Post Consolidation

for
CNS Embryonal Tumor, CNS, Medulloblastoma,
Location: Montreal, Sherbrooke, Ottawa, Quebec, Toronto, Hamilton,
Sponsor: C17 Council

Sex: All

Age: 0 - 6

Code: NCT06942039

Early Phase 1, Recruiting
Active & Responsive

Testing a Standardized Approach to Surgery and Chemotherapy for Type I Pleuropulmonary Blastoma or the Addition of an Anti-cancer Drug, Topotecan, to the Usual Treatment for Types II and III Pleuropulmonary Blastoma

for
Pleuropulmonary Blastoma
Location: Montreal, Sherbrooke, Quebec, Albany NY, Boston MA,
Sponsor: Children's Oncology Group

Sex: All

Age: 0 - 21

Code: NCT06647953

Phase 3, Recruiting
Active & Responsive

BBD Longitudinal Study of Osteogenesis Imperfecta

for
Osteogenesis Imperfecta
Location: Montreal, New York NY, Wilmington DE, Baltimore MD,
Sponsor: Baylor College of Medicine

Sex: All

Age: 0+

Code: NCT02432625

Recruiting
Active & Responsive

BEATRIX: A Study to Learn About a Group B Streptococcus Vaccine in Healthy Pregnant Women and Their Babies

for
Healthy
Location: Montreal, Ottawa, Quebec, Kingston, Boston MA,
Sponsor: Pfizer

Sex: All

Age: 0 - 49

Code: NCT07160244

Phase 3, Recruiting
Active & ResponsiveNew

A Study of KarXT + KarX-EC for Treatment of Irritability in Children and Adolescents With Autism

for
Irritability Associated With Autism Spectrum Disorder
Location: Montreal, Chicago IL, Glendale CA, San Rafael CA
Sponsor: Bristol-Myers Squibb

Sex: All

Age: 5 - 17

Code: NCT07284745

Phase 3, Recruiting
Active & Responsive

Concurrent Versus Sequential Administration of Tdap and RSV Vaccines in Pregnancy

for
RSV,
Location: Montreal, Ottawa, Halifax
Sponsor: Canadian Immunization Research Network

Sex: Female

Age: 18 - 49

Code: NCT07097012

Phase 4, Recruiting
Active & Responsive

Interventional Study of Infigratinib in Children < 3 Years Old With Achondroplasia (ACH)

for
Achondroplasia
Location: Montreal, Ottawa, Baltimore MD, Madison WI, Oakland CA
Sponsor: QED Therapeutics, a BridgeBio company

Sex: All

Age: 0 - 2

Code: NCT07169279

Phase 2, Recruiting
Active & Responsive

Comprehensive Assessment of Neurodegeneration and Dementia

for
Dementia, Mild Cognitive Impairment (MCI),
Location: Montreal, Quebec, Toronto, Hamilton, London, Halifax,
Sponsor: McGill University

Sex: All

Age: 50 - 70+

Code: NCT03402919

Recruiting
Active & Responsive

A Gaucher Disease Gene Therapy Trial With FLT201

for
Gaucher Disease Type 1
Location: Montreal, Hackensack NJ, New York NY, Philadelphia PA,
Sponsor: Spur Therapeutics

Sex: All

Age: 18+

Code: NCT07223944

Phase 3, Recruiting
Active & Responsive

Tebentafusp Regimen Versus Investigator's Choice in Previously Treated Advanced Melanoma (TEBE-AM)

for
Advanced Melanoma
Location: Montreal, Boston MA, Toronto, Lake Success NY,
Sponsor: Immunocore Ltd

Sex: All

Age: 18+

Code: NCT05549297

Phase 3, Recruiting
Active & Responsive

A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH

for
NASH - Nonalcoholic Steatohepatitis,
Location: Montreal, Terrebonne, Rochester NY, New Haven CT,
Sponsor: Akero Therapeutics, Inc

Sex: All

Age: 18 - 70+

Code: NCT06528314

Phase 3, Recruiting